Curriculum vitae PERSONAL INFORMATION Giacomo Grassi Via Dei Serragli 33, 50124 Florence (Italy) (+39) 3475337031 [email protected] Skype giacomograssi Sex Male | Date of birth 19/11/1984 | Nationality Italian WORK EXPERIENCE 15/06/2015–Present Clinical and research activity Institute of Neuroscience, Florence (Italy) 17/05/2003–17/05/2009 Clinical activity at the Psychiatric Unit of the University of Florence EDUCATION AND TRAINING 17/05/2010–17/05/2015 Residency in Psychiatry 70/70 cum laude University of Florence, Florence (Italy) Dissertation’s title: “Atomoxetine for hoarding disorder: a pre-clinical and clinical investigation”. Superviisors: Prof. Stefano Pallanti M.D., Ph.D. , Prof. Carla Ghelardini Ph.D. 01/10/2013–01/02/2014 Internship at the University of Amsterdam Academic Medical Center, Amsterdam (Netherlands) Training and research activity on Deep-Brain Stimulation for Obsessive-Compulsive Disorder and Mood Disorders. Supervisors: Damiaan Denys, M.D., Ph.D. and Martijn Figee, M.D., Ph.D. 01/01/2007–31/10/2007 Long Life Learning Program Universitée René Descartes, Paris (France) Clinical activity in otrhopedic surgery at Hopital Cochin (Paris V) Clinical activity in interna medicine at Hopital Saint Michel (Paris XIII) 10/2003–19/10/2009 Graduation in Medicine and Surgery 110/110 University of Florence, Florence (Italy) Dissertation’s title: “Aripiprazole augmentation for obsessive-compulsive patients with treatmentresistance to the association SSRI + risperidone: a single-blinded study”. Superviisor: Prof. Stefano Pallanti M.D., Ph.D. PERSONAL SKILLS Mother tongue(s) Other language(s) Italian UNDERSTANDING Listening 16/7/15 Reading SPEAKING Spoken interaction © European Union, 2002-2015 | http://europass.cedefop.europa.eu WRITING Spoken production Page 1 / 3 Curriculum vitae English French Giacomo Grassi C1 C1 C1 C1 B2 C1 C1 C1 C1 B2 Levels: A1 and A2: Basic user - B1 and B2: Independent user - C1 and C2: Proficient user Common European Framework of Reference for Languages ADDITIONAL INFORMATION Memberships International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Italian Society of Psychiatry (SIP) Honours and awards Publications Fellowship Award 2015 for youngpsychiatrist of the Japanese Society of Psychiatry and Neurology. JSPN-WPA congress, Osaka (Japan) june 4th-6th2015 Peerreviewed papers Grassi G, Godini L, Grippo A, Piccagliani D, Pallanti S. Enhancing cognitive-behavioral therapy with repetitive transcranial magnetic stimulation in refractory obsessive-compulsive disorder: a case report. BrainStimul. 2015 Jan-Feb;8(1):160-1 Pallanti S, Grassi G, Pharmacologic treatment of obsessive-compulsive disorder comorbidity. Expert Opin Pharmacother. 2014 Dec; 15(17): 2543-52. Pallanti S, Grassi G, Cantisani A. Emerging drugs to treatobsessive-compulsive disorder. Expert Opin Emerg Drugs. 2014 Mar;19(1):67-77. Pallanti S, Grassi G, Antonini S, Quercioli L, Salvadori E, Hollander E. rTMSin resistant mixed states: an exploratory study. J Affect Disord.,157:66-71;2014. GrassiG, Poli L,Cantisani A, Righi L, Ferrari G, Pallanti S. Hypochondriasis and obsessivecompulsivedisorder in schizophrenic patients treated with clozapine vs other atypicalantipsychotics. CNS Spectrum, 2014;19(4):340-6. Grassi G, Pallanti S. Citalopram Pulse-Loading forSevere Treatment-Resistant OCD: A Case Series of Acute Response, One YearFollow-Up and Tolerability. J Depress Anxiety, 2013. Pallanti S, Grassi G, Tofani L, Spitoni S. Pharmacologicaltreatments for behavioral addictions: from behavioral dimensions to theResearch Domain Criteria based target. Current Psychopharmacology. 2013. Pallanti S, Grassi G, Ramella-Cravaro V. From psychopatology toneurocircuits: what we can learn from DBS? The case of obsessive-compulsivedisorder. Journal of Psychopathology. 2013, in press Pallanti S, Cantisani A, Grassi G. Anxiety as a core aspect of schizophrenia. Curr Psychiatry Rep.2013, 15(5):354. Pallanti S,Grassi G, Cantisani A. Is hoarding aseparate disorder? Neuropsychiatry, 2012, 2(5): 365367. Pallanti S, Cantisani A, Grassi G, Antonini S, Cecchelli C,Burian J, Cauli G, Quercioli L. rTMS agedependent response intreatment-resistant depressed subjects: a mini-review. CNS Spectr. 2012, 17(1):24-30. Pallanti S, Grassi G, Burian J. Dopamine Pharmacological Agents in Resistant-OCD.Current Psychopharmacology, 2012, 1: 44-46 Pallanti S, Grassi G, Sarrecchia ED, Cantisani A, Pellegrini M.Obsessive-compulsive disorder comorbidity: clinical assessment and therapeuticimplications. Front Psychiatry. 2011, 2:70. Cecchelli C, Grassi G, Pallanti S. Aripiprazole Improves Depressive Symptoms andImmunological Response to Antiretroviral Therapy in an HIV-Infected Subjectwith Resistant Depression. Case Report Med. 2010. Bookchapters Pallanti S, Grassi G, Cantisani A. Approachesto treatment resistance. Obsessive Compulsive Disorder: Current Science andClinical Practice. World Psychiatry Association. Wiley-Blackwell (Ed.). 16/7/15 © European Union, 2002-2015 | http://europass.cedefop.europa.eu Page 2 / 3 Curriculum vitae Giacomo Grassi 2012 Pallanti S, Grassi G, Cantisani A. The Treatment of Obsessive-CompulsiveDisorder and the Approaches to Treatment Resistance, Different Views of AnxietyDisorders, Salih Selek (Ed.), ISBN: 978-953-307-560-0, InTech. 2011 Presentations “Newconceptualizations of obsessive-compulsive disorder: the behavioral addictionmodel” JSPNWPA congress 2015, 4th-6th June, Osaka,Japan. “Neuroscientif tools for forensic psychiatry”JSPN-WPA congress 2015, 4th-6th June, Osaka, Japan. "Impulsivity, decision-making and reward functioning in obsessive-compulsive disorder (OCD) and pathological gambling: probing the behavioral addiction model of OCD". 2nd International Conference on Behavioral Addictions, March 16-18, 2015, Budapest, Hungary. “Reduced loss avoidance and overconfidence in obsessive-compulsivedisorder: a neuroeconomic perspective”. EPA European Psychiatric Congress 2014,1-4 March, Munich, Germany “Obsessive–compulsive disorder clinical staging: From endophenotype tobehavioral addiction”. 1stInternational Conference on Behavioral Addictions March 11–12, 2013 Budapest,Hungary “Workshop on Obsessive Compulsive-Disorder”. October 26, 2012 Lugano,Switzerland. Posters "Citalopram pulse-loading for treatment-refractory obsessive-compulsive disorder: preliminary data from an open-label trial". Grasssi G and Pallanti S. 25th ECNP Congress 18-21 October 2014, Berlin, Germany. “Obsessive–compulsive disorder clinical staging: From endophenotype tobehavioral addiction: a theoretical framework”. Grassi G. EPA European Psychiatric Congress 2014, 1-4March, Munich, Germany “Hypochondrias and obsessive-compulsive disorder in schizophrenicpatients treated with clozapine vs other atypical antipsychotics”. Grassi G,Poli L, Pellegrini M, Pallanti S. 25thECNP Congress13-17 October 2012, Vienna, Austria. Web Intervies http://www.newscientist.com/article/mg22129603.400... Research fields Obsessive-Compulsive and related Disorders Impulsivity and Compulsivity Decision-making Behavioral Addictions Neuromodulation tecniques 16/7/15 © European Union, 2002-2015 | http://europass.cedefop.europa.eu Page 3 / 3